PARPi: Precision Medicine in Advanced Prostate Cancer

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to TestПодробнее

PARPi: Precision Medicine in Advanced Prostate Cancer (2023)Подробнее

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)Подробнее

PARP Inhibitors in 2020: Where Are We Now, and Where Are We Going | Webinar | Ambry GeneticsПодробнее

Dr. Matthew Rettig Discusses Precision Medicine in Advanced Prostate CancerПодробнее

Dr. Daniel Spratt Discusses Phenotypic Precision Medicine in Advanced Prostate CancerПодробнее

Daniel George, MD on Precision Medicine Approaches in APC - Part 2Подробнее

Dr. Andrew Armstrong on Precision Medicine Approaches in Advanced Prostate CancerПодробнее

Daniel George, MD on Precision Medicine Approaches in APC - Part 1Подробнее

The Current Landscape of Phenotypic Precision Medicine for Advanced Prostate CancerПодробнее

PARPi olaparib for the targeted treatment of metastatic prostate cancerПодробнее

How is Precision Medicine Utilized in Advanced Prostate Cancer?Подробнее

The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее

PARP Inhibitors: Best Practices In Advanced Prostate Cancer Care In The CommunityПодробнее

Precision Medicine in Prostate CancerПодробнее

Updates in precision medicine for prostate cancerПодробнее

Prostate cancer updates: Advances in precision medicine and PARP inhibitorsПодробнее

M1 CRPC: PARP Inhibitors and Precision MedicineПодробнее

The Role of PARP Inhibitors in Advanced Prostate Cancer (2023)Подробнее

How Precision Medicine is Revolutionizing Cancer TreatmentПодробнее

Dr. Gomella Discusses Precision Medicine in Prostate CancerПодробнее